Wall Street analysts predict that athenahealth, Inc (NASDAQ:ATHN) will announce $0.73 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Twenty Two analysts have made estimates for athenahealth’s earnings. The lowest EPS estimate is $0.38 and the highest is $0.90. athenahealth reported earnings of $0.32 per share during the same quarter last year, which indicates a positive year over year growth rate of 128.1%. The firm is scheduled to report its next earnings report on Thursday, April 26th.
On average, analysts expect that athenahealth will report full-year earnings of $3.76 per share for the current financial year, with EPS estimates ranging from $3.10 to $4.15. For the next financial year, analysts forecast that the firm will report earnings of $4.47 per share, with EPS estimates ranging from $3.72 to $5.42. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that follow athenahealth.
athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.48. The company had revenue of $329.20 million during the quarter, compared to the consensus estimate of $319.64 million. athenahealth had a net margin of 4.35% and a return on equity of 9.21%. athenahealth’s revenue was up 14.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.62 earnings per share.
Shares of athenahealth (NASDAQ:ATHN) traded up $3.00 on Thursday, reaching $147.85. 484,455 shares of the company’s stock were exchanged, compared to its average volume of 384,191. The stock has a market capitalization of $5,928.49, a PE ratio of 87.49, a PEG ratio of 2.56 and a beta of 1.17. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32. athenahealth has a twelve month low of $95.01 and a twelve month high of $158.66.
In related news, CMO Timothy John O’brien sold 3,064 shares of the stock in a transaction that occurred on Friday, March 2nd. The shares were sold at an average price of $137.27, for a total transaction of $420,595.28. Following the transaction, the chief marketing officer now owns 11,320 shares in the company, valued at $1,553,896.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Jonathan Bush sold 250 shares of the stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $139.27, for a total transaction of $34,817.50. Following the transaction, the chief executive officer now owns 321,533 shares in the company, valued at approximately $44,779,900.91. The disclosure for this sale can be found here. In the last quarter, insiders have sold 108,705 shares of company stock worth $14,891,199. Corporate insiders own 3.20% of the company’s stock.
A number of institutional investors have recently modified their holdings of the stock. Fairfield Bush & CO. lifted its position in athenahealth by 154.4% during the fourth quarter. Fairfield Bush & CO. now owns 4,752 shares of the health services provider’s stock valued at $632,000 after purchasing an additional 2,884 shares during the period. Xact Kapitalforvaltning AB bought a new position in athenahealth during the fourth quarter valued at approximately $537,000. LPL Financial LLC bought a new position in athenahealth during the fourth quarter valued at approximately $207,000. Meadow Creek Investment Management LLC bought a new position in athenahealth during the fourth quarter valued at approximately $132,000. Finally, Teachers Advisors LLC lifted its position in athenahealth by 1.3% during the fourth quarter. Teachers Advisors LLC now owns 76,554 shares of the health services provider’s stock valued at $10,185,000 after purchasing an additional 1,002 shares during the period.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.